-------------------------------ADVERSE REACTIONS------------------------------ The most common adverse reactions observed in clinical trials were application site reactions, which occurred in less than 1% of subjects. (6.1)
-------------------------------ADVERSE REACTIONS------------------------------ The most common adverse reactions observed in clinical trials were application site reactions, which occurred in less than 1% of subjects. (6.1)